Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating expenses:
Research and development expenses	$ 1,030,003	$ 201,138
General and administrative expenses	3,905,877	535,801
Total operating expenses	4,935,880	736,939
Loss from operations	(4,935,880)	(736,939)
Other income (expense):
Gain on bargain purchase	11,729,882	0
Interest income	23,302	6
Interest expense	(606)	(959)
Net income (loss)	6,816,698	(737,892)
Comprehensive income (loss)	$ 6,816,698	$ (737,892)
Per share information:
Net income (loss) per share, basic (in dollars per share)	$ 1.82	$ (0.24)
Net income (loss) per share, diluted (in dollars per share)	$ 1.47	$ (0.24)
Weighted average common shares outstanding, basic (in shares)	3,748,325	3,099,311
Weighted average common shares outstanding, diluted (in shares)	4,625,295	3,099,311